Unknown

Dataset Information

0

Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma.


ABSTRACT: 3?-Hydroxysteroid-?24 reductase (DHCR24), the final enzyme of the cholesterol biosynthetic pathway, has been associated with urogenital neoplasms. However, the function of DHCR24 in endometrial cancer (EC) remains largely elusive. Here, we analyzed the expression profile of DHCR24 and the progesterone receptor (PGR) in our tissue microarray of EC (n?=?258), the existing EC database in GEO (Gene Expression Omnibus), and TCGA (The Cancer Genome Atlas). We found that DHCR24 was significantly elevated in patients with EC, and that the up-regulation of DHCR24 was associated with advanced clinical stage, histological grading, vascular invasion, lymphatic metastasis, and reduced overall survival. In addition, DHCR24 expression could be induced by insulin though STAT3, which directly binds to the promoter elements of DHCR24, as demonstrated by ChIP-PCR and luciferase assays. Furthermore, genetically silencing DHCR24 inhibited the metastatic ability of endometrial cancer cells and up-regulated PGR expression, which made cells more sensitive to progestin. Taken together, we have demonstrated for the first time the crucial role of the insulin/STAT3/DHCR24/PGR axis in the progression of EC by modulating the metastasis and progesterone response, which could serve as potential therapeutic targets for the treatment of EC with progesterone receptor loss.

SUBMITTER: Dai M 

PROVIDER: S-EPMC5256103 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cholesterol Synthetase DHCR24 Induced by Insulin Aggravates Cancer Invasion and Progesterone Resistance in Endometrial Carcinoma.

Dai Miao M   Zhu Xiao-Lu XL   Liu Fei F   Xu Qin-Yang QY   Ge Qiu-Lin QL   Jiang Shu-Heng SH   Yang Xiao-Mei XM   Li Jun J   Wang Ya-Hui YH   Wu Qing-Kai QK   Ai Zhi-Hong ZH   Teng Yin-Cheng YC   Zhang Zhi-Gang ZG  

Scientific reports 20170123


3β-Hydroxysteroid-Δ24 reductase (DHCR24), the final enzyme of the cholesterol biosynthetic pathway, has been associated with urogenital neoplasms. However, the function of DHCR24 in endometrial cancer (EC) remains largely elusive. Here, we analyzed the expression profile of DHCR24 and the progesterone receptor (PGR) in our tissue microarray of EC (n = 258), the existing EC database in GEO (Gene Expression Omnibus), and TCGA (The Cancer Genome Atlas). We found that DHCR24 was significantly elevat  ...[more]

Similar Datasets

| S-EPMC7686505 | biostudies-literature
| S-EPMC8155186 | biostudies-literature
| S-EPMC8675944 | biostudies-literature
| S-EPMC5740891 | biostudies-literature
| S-EPMC6391799 | biostudies-literature
| S-EPMC5352432 | biostudies-literature
| S-EPMC3934726 | biostudies-literature
| S-EPMC7451763 | biostudies-literature
| S-EPMC9179553 | biostudies-literature
| S-EPMC2753607 | biostudies-literature